同仁堂国药(03613)发布公告,董事会宣布人事变动。由于工作安排变更,陈飞已于2025年5月12日辞任公司执行董事、常务副总经理及授权代表。陈飞确认与董事会及公司之间没有意见分歧,且其辞任不需提请股东或联交所关注。
同时,乐拯和严晗被委任为公司执行董事。乐拯自2025年5月12日起担任公司副主席,严晗则担任竞争执行委员会成员及授权代表。乐拯在公司任职期间表现出色,曾担任多个职务,现为国家级非物质文化遗产项目的代表性传承人。两位新任董事的任期均为三年,且在任职期间不收取任何董事袍金。
(文章来源:财中社)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.